MEREO BIOPHARMA GROUP PLC Payments To Acquire Or Redeem Entitys Shares
MEREO BIOPHARMA GROUP PLC (MREO) reported Payments To Acquire Or Redeem Entitys Shares of GBP 998.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2022-03-31.
Discontinued › Cash Flow › Investing Activities
ifrs-full:PaymentsToAcquireOrRedeemEntitysShares · last filed 2022-03-31
| Period end | Payments To Acquire Or Redeem Entitys Shares 6 month | Payments To Acquire Or Redeem Entitys Shares 12 month | Payments To Acquire Or Redeem Entitys Shares 12 month as first filed |
|---|---|---|---|
| 2019-12-31 | 998.00K GBP 20-F · filed 2022-03-31 | ||
| 2019-06-30 | 998.00K GBP 6-K · filed 2020-09-29 | ||
| 2018-12-31 | 307.00K GBP 20-F · filed 2021-03-31 | 306.84K GBP 20-F/A · filed 2019-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |